34 related articles for article (PubMed ID: 38449316)
21. Intrapleural tissue plasminogen activator for the treatment of parapneumonic effusion.
Hamblin SE; Furmanek DL
Pharmacotherapy; 2010 Aug; 30(8):855-62. PubMed ID: 20653362
[TBL] [Abstract][Full Text] [Related]
22. Streptokinase and urokinase for the treatment of pleural effusions and empyemas.
Barletta JF
Ann Pharmacother; 1999 Apr; 33(4):495-8. PubMed ID: 10332542
[TBL] [Abstract][Full Text] [Related]
23. Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients.
Israel EN; Blackmer AB
Pharmacotherapy; 2014 May; 34(5):521-32. PubMed ID: 24390857
[TBL] [Abstract][Full Text] [Related]
24. Utility of fibrinolytic agents for draining intrapleural infections.
Bouros D; Schiza S; Siafakas N
Semin Respir Infect; 1999 Mar; 14(1):39-47. PubMed ID: 10197396
[TBL] [Abstract][Full Text] [Related]
25. Surgical versus non-surgical management for pleural empyema.
Redden MD; Chin TY; van Driel ML
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010651. PubMed ID: 28304084
[TBL] [Abstract][Full Text] [Related]
26. [Using of fibrinolytics in the treatment of complicated parapneumonic effusion and empyema in children].
Uyan AP; Ozyürek H; Yilmaz E
Tuberk Toraks; 2003; 51(3):320-4. PubMed ID: 15143413
[TBL] [Abstract][Full Text] [Related]
27. Use of fibrinolytic agents in the management of complicated parapneumonic effusions and empyemas.
Sahn SA
Thorax; 1998 Aug; 53 Suppl 2(Suppl 2):S65-72. PubMed ID: 10193351
[TBL] [Abstract][Full Text] [Related]
28. Intrapleural fibrinolytic treatment of multiloculated thoracic empyemas.
Robinson LA; Moulton AL; Fleming WH; Alonso A; Galbraith TA
Ann Thorac Surg; 1994 Apr; 57(4):803-13; discussion 813-4. PubMed ID: 8166523
[TBL] [Abstract][Full Text] [Related]
29. Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema.
Singh G; Pitoyo CW; Nasir AU; Rumende CM; Amin Z
Acta Med Indones; 2012 Jul; 44(3):258-64. PubMed ID: 22983084
[TBL] [Abstract][Full Text] [Related]
30. INTRAPLEURAL FIBRINOLYSIS WITH UROKINASE VERSUS ALTEPLASE IN COMPLICATED PLEURAL EFFUSIONS AND EMPYEMA: A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL.
Adhikari S; Marwah V; Choudhary R; Pandey IM; Kumar TA; Malik V; Pemmaraju A; V S; Kapoor S
Tuberc Respir Dis (Seoul); 2024 Mar; ():. PubMed ID: 38449316
[TBL] [Abstract][Full Text] [Related]
31. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema.
Cameron R; Davies HR
Cochrane Database Syst Rev; 2004; (2):CD002312. PubMed ID: 15106174
[TBL] [Abstract][Full Text] [Related]
32. Intra-pleural fibrinolytic therapy vs. conservative management in the treatment of parapneumonic effusions and empyema.
Cameron R
Cochrane Database Syst Rev; 2000; (3):CD002312. PubMed ID: 10908554
[TBL] [Abstract][Full Text] [Related]
33. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema.
Cameron R; Davies HR
Cochrane Database Syst Rev; 2008 Apr; (2):CD002312. PubMed ID: 18425881
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials.
Nie W; Liu Y; Ye J; Shi L; Shao F; Ying K; Zhang R
Clin Respir J; 2014 Jul; 8(3):281-91. PubMed ID: 24428897
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
